Vagal mediation of GLP-1's effects on food intake and glycemia
The modification is widely involved in cell metabolism, proliferation, differentiation, and apoptosis by affecting protein stability, activity, subcellular localization, and protein interaction (Dang and Wei, 2022)
The FDA warns that some patients and health care professionals may look to unapproved versions of GLP-1 (glucagon-like peptide-1 (GLP-1) receptor agonists) drugs for weight loss, potentially exposing consumers to counterfeit or unsafe products
When considering which has fewer side effects, its important to look at the common issues associated with each drug
Brain Struct Funct (2012) 218:37388.10.1007/s00429-012-0402-9 127 Labandeira-GarciaJLRodriguez-PallaresJVillar-ChedaBRodriguez-PerzAIGarrido-GilPGuerraMJ